BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22389068)

  • 1. A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia.
    Lambert MP; Jiang J; Batra V; Wu C; Tong W
    Am J Hematol; 2012 May; 87(5):532-4. PubMed ID: 22389068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.
    Higgs JR; Sadek I; Neumann PE; Ing VW; Renault NK; Berman JN; Greer WL
    Leukemia; 2008 Aug; 22(8):1551-6. PubMed ID: 18496561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPL W515L mutation in pediatric essential thrombocythemia.
    Farruggia P; D'Angelo P; La Rosa M; Scibetta N; Santangelo G; Lo Bello A; Duner E; Randi ML; Putti MC; Santoro A
    Pediatr Blood Cancer; 2013 Aug; 60(8):E52-4. PubMed ID: 23441089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential thrombocythaemia with mutation in
    Alvarez-Larran A; Martínez D; Arenillas L; Rubio A; Arellano-Rodrigo E; Hernández Boluda JC; Papaleo N; Caballero G; Martínez C; Ferrer-Marín F; Mata MI; Pérez-Encinas M; Durán MA; Alonso JM; Carreño-Tarragona G; Alonso JM; Noya S; Magro E; Pérez R; López-Guerra M; Pastor-Galán I; Cervantes F; Besses C; Colomo L; Rozman M
    J Clin Pathol; 2018 Nov; 71(11):975-980. PubMed ID: 29934356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2V617F, CALR, and MPL Mutations and Bone Marrow Histology in Patients with Essential Thrombocythaemia.
    Pich A; Riera L; Francia di Celle P; Beggiato E; Benevolo G; Godio L
    Acta Haematol; 2018; 140(4):234-239. PubMed ID: 30404086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rare Case of Essential Thrombocythemia with Coexisting
    Jang MA; Seo MY; Choi KJ; Hong DS
    J Korean Med Sci; 2020 Jun; 35(23):e168. PubMed ID: 32537949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
    Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
    Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients.
    Cabagnols X; Favale F; Pasquier F; Messaoudi K; Defour JP; Ianotto JC; Marzac C; Le Couédic JP; Droin N; Chachoua I; Favier R; Diop MK; Ugo V; Casadevall N; Debili N; Raslova H; Bellanné-Chantelot C; Constantinescu SN; Bluteau O; Plo I; Vainchenker W
    Blood; 2016 Jan; 127(3):333-42. PubMed ID: 26450985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of MPL W515L/K mutations in patients with primary myelofibrosis and essential thrombocythaemia by allele-specific polymerase chain reaction.
    Daly S; Conneally E; Langabeer SE
    Acta Haematol; 2009; 121(4):221-2. PubMed ID: 19521067
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
    Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
    Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
    Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin Measurement as a Key Component in the Evaluation of Pediatric Thrombocytosis.
    Nelson ND; Marcogliese A; Bergstrom K; Scheurer M; Mahoney D; Bertuch AA
    Pediatr Blood Cancer; 2016 Aug; 63(8):1484-7. PubMed ID: 27100794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential thrombocythemia with Mpl W515 K mutation in a child presenting with Budd-Chiari syndrome.
    Tokgoz H; Caliskan U; Yüksekkaya HA; Kucukkaya R
    Platelets; 2015; 26(8):805-8. PubMed ID: 25970554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
    Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
    Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines.
    Dillon M; Minear J; Johnson J; Lannutti BJ
    Leuk Res; 2008 May; 32(5):811-9. PubMed ID: 17980909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.
    Milosevic Feenstra JD; Nivarthi H; Gisslinger H; Leroy E; Rumi E; Chachoua I; Bagienski K; Kubesova B; Pietra D; Gisslinger B; Milanesi C; Jäger R; Chen D; Berg T; Schalling M; Schuster M; Bock C; Constantinescu SN; Cazzola M; Kralovics R
    Blood; 2016 Jan; 127(3):325-32. PubMed ID: 26423830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.
    Sangkhae V; Etheridge SL; Kaushansky K; Hitchcock IS
    Blood; 2014 Dec; 124(26):3956-63. PubMed ID: 25339357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel MPL point mutation resulting in thrombopoietin-independent activation.
    Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
    Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
    Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
    Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.